An Explorative Trial Evaluating the Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)

Trial Profile

An Explorative Trial Evaluating the Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Nov 2015

At a glance

  • Drugs LEO 39652 (Primary)
  • Indications Atopic dermatitis
  • Focus Therapeutic Use
  • Sponsors LEO Pharma
  • Most Recent Events

    • 01 Feb 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 21 Aug 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top